Form EFFECT ADC Therapeutics SA
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | March 16, 2026 4:00 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ADC Therapeutics SA (ADCT) Tops Q2 EPS by 11c
- ADC Therapeutics Reports Second Quarter 2026 Financial Results and Provides Operational Updates
- Security and Data-Residency Reviews Push Enterprise AI Buyers Toward Self-Hosted Platforms, and FastGPT Publishes Its Terms
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
